Advertisement
Research Article| Volume 21, ISSUE 3, P475-494, September 2001

Clinicopathologic Features of Viral Agents of Potential Use by Bioterrorists

DOI:https://doi.org/10.1016/S0272-2712(18)30019-2
Clinicopathologic Features of Viral Agents of Potential Use by Bioterrorists
Previous ArticleClinical Recognition and Management of Patients Exposed to Biological Warfare Agents
Next ArticleThe Laboratory Role in Diagnosis of Infections Transmitted by Arthropods
      This paper is only available as a PDF. To read, Please Download here.
      Concerns regarding the possible use of viral agents as weapons of mass destruction have heightened our need to recognize disease syndromes caused by these pathogens and to increase our understanding of potential countermeasures. This article reviews the clinical and pathologic features of various viruses that are generally thought to be potential biowarfare threats, and other related agents of topical interest. The epidemiologic and clinical aspects of recent natural outbreaks of disease caused by exotic viral agents are briefly described. Viral tissue targets, immune responses to these agents, relevant animal models, and diagnostic and potential therapeutic modalities also are discussed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Armstrong L.R.
        • Dembry L.M.
        • Rainey P.M.
        • et al.
        Management of a Sabia virus-infected patient in a US hospital.
        Infect Control Hosp Epidemiol. 1999; 20: 176-182
        • Asnis D.S.
        • Conetta R.
        • Teixeira A.A.
        • et al.
        The West Nile Virus outbreak of 1999 in New York: The Flushing Hospital experience.
        Clin Infect Dis. 2000; 30: 413-418
        • Bowen G.S.
        • Fashinell T.R.
        • Dean P.B.
        • et al.
        Clinical aspects of human Venezuelan equine encephalitis in Texas.
        Bulletin of the PAHO. 1976; 10: 46-57
        • Bowen G.S.
        • Rayfield E.J.
        • Monath T.P.
        • et al.
        Studies of glucose metabolism in rhesus monkeys after Venezuelan equine encephalitis virus infection.
        J Med Virol. 1980; 6: 227-234
        • Bray M.
        • Martinez M.
        • Smee D.F.
        • et al.
        Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
        J Infect Dis. 2000; 181: 10-19
        • Briggiler A.M.
        • Levis S.
        • Enrin D.
        Argentine hemorrhagic fever in pregnant women.
        Medicine. 1990; 50: 443
        • Bwaka M.A.
        • Bonnet M.J.
        • Calain P.
        • et al.
        Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients.
        J Infect Dis. 1999; 179: S1-7
        • Calisher C.H.
        • Kinney R.M.
        • de Souza Lopes O.
        • et al.
        Identification of a new Venezuelan equine encephalitis virus from Brazil.
        Am J Trop Med Hyg. 1982; 31: 1260-1272
        • Centers for Disease Control and Prevention
        Surveillance for West Nile virus in overwintering mosquitoes—New York, 2000.
        JAMA. 2000; 282: 2380-2381
        • Charles P.C.
        • Walters E.
        • Margolis F.
        • et al.
        Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse.
        Virology. 1995; 208: 662-671
        • Chen J.P.
        • Cosgriff T.M.
        Hemorrhagic fever virus-induced changes in hemostasis and vascular biology.
        Blood Coagul Fibrinolysis. 2000; 11: 461-483
        • Councilman W.T.
        • Magrath G.B.
        • Brincherhoff W.R.
        The pathologic anatomy and histology of variola.
        J Med Res. 1904; 11: 12-135
        • Davis K.J.
        • Anderson A.O.
        • Geisbert T.W.
        • et al.
        Pathology of experimental Ebola virus infection in African green monkeys: Involvement of fibroblastic reticular cells.
        Arch Pathol Lab Med. 1997; 121: 805-819
        • Davis N.L.
        • Caley I.J.
        • Brown K.W.
        • et al.
        Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.
        J Virol. 2000; 74: 371-378
        • Davis N.L.
        • Powell N.
        • Greenwald G.F.
        • et al.
        Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone.
        Virology. 1991; 183: 20-31
        • Davis N.L.
        • Willis L.V.
        • Smith J.F.
        • et al.
        In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: Analysis of a viable deletion mutant.
        Virology. 1989; 171: 189-204
        • de Manzione N.
        • Salas R.A.
        • Paredes H.
        • et al.
        Venezuelan hemorrhagic fever: Clinical and epidemiological studies of 165 cases.
        Clin Infect Dis. 1998; 26: 308-313
        • de Silva A.M.
        • Dittus W.P.
        • Amerasinghe P.H.
        • et al.
        Serologic evidence for an epizootic dengue virus infecting toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka.
        Am J Trop Med Hyg. 1999; 60: 300-306
      19. Ebola virus infection in imported primates—Virginia, 1989.
        MMWR Morb Mortal Wkly Rep. 1989; 38 (837-838): 831-832
        • Ebola Haemorrhagic Fever (EHF) in Uganda - Update 40
        Communicable Disease Surveillance and Response (CSR). World Health Organization, Geneva2001
        • Enria D.
        • Franco S.G.
        • Ambrosio A.
        • et al.
        Current status of the treatment of Argentine Hemorrhagic Fever.
        Med Microbiol Immunol. 1986; 175: 173-176
        • Enria D.A.
        • Maiztegui J.I.
        Antiviral treatment of Argentine hemorrhagic fever.
        Antiviral Res. 1994; 23: 23-31
        • Fenner F.
        Poxviruses.
        in: Fields B. Knipe D. Howley P. Fields Virology. ed 3. Lippincott-Raven, Philadelphia1996: 2675-2699
        • Fenner F.
        • Henderson D.A.
        • Arita I.
        • et al.
        Smallpox and Its Eradication. World Health Organization, Geneva1988
        • Feuerstein G.Z.
        • Liu T.
        • Barone F.C.
        Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-alpha.
        Cerebrovasc Brain Metab Rev. 1994; 6: 341-360
        • Foege W.H.
        Commentary: Smallpox eradication in west and central Africa revisited.
        Bull World Health Organ. 1998; 76: 233-235
        • Frame J.D.
        Clinical features of Lassa fever in Liberia.
        Rev Infect Dis. 1989; 11: S783-789
        • Freed E.R.
        • Duma R.J.
        • Escobar M.R.
        Vaccinia necrosum and its relationship to impaired immunologic responsiveness.
        Am J Med. 1972; 52: 411-420
        • Gallimore A.
        • Hengartner H.
        • Zinkernagel R.
        Hierarchies of antigen-specific cytotoxic T-cell responses.
        Immunol Rev. 1998; 164: 29-36
        • Garcia-Tamayo J.
        • Carreno G.
        • Esparza J.
        Central nervous system alterations as sequelae of Venezuelan equine encephalitis virus infection in the rat.
        J Pathol. 1979; 128: 87
        • Goh K.J.
        • Tan C.T.
        • Chew N.K.
        • et al.
        Clinical features of Nipah virus encephalitis among pig farmers in Malaysia [see comments].
        N Engl J Med. 2000; 342: 1229-1235
        • Grieder F.B.
        • Davis B.K.
        • Zhou X.D.
        • et al.
        Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
        Virology. 1997; 233: 302-312
        • Grieder F.B.
        • Davis N.L.
        • Aronson J.F.
        • et al.
        Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
        Virology. 1995; 206: 994-1006
        • Grieder F.B.
        • Nguyen H.T.
        Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages.
        Microb Pathog. 1996; 21: 85-95
        • Grieder F.B.
        • Vogel S.N.
        Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
        Virology. 1999; 257: 106-118
        • Gunther S.
        Imported Lassa fever in Germany: Molecular characterization of a new Lassa virus strain.
        Emerg Infect Dis. 2000; 6: 466-476
        • Hart M.K.
        • Caswell-Stephan K.
        • Bakken R.
        • et al.
        Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
        Vaccine. 2000; 18: 3067-3075
        • Hart M.K.
        • Pratt W.
        • Panelo F.
        • et al.
        Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
        Vaccine. 1997; 15: 363-369
        • Henderson D.
        Bioterrorism as a public health threat.
        Emerg Infect Dis. 1998; 4: 488-492
        • Henderson D.A.
        Smallpox: Clinical and epidemiologic features.
        Emerg Infect Dis. 1999; 5: 537-539
        • Hevey M.
        • Negley D.
        • Pushko P.
        • et al.
        Marburg virus vaccines based upon alpha virus replicons protect guinea pigs and nonhuman primates.
        Virology. 1998; 251: 28-37
        • Heymann D.L.
        • Szczeniowski M.
        • Esteves K.
        Re-emergence of monkeypox in Africa: A review of the past six years.
        Br Med Bull. 1998; 54: 693-702
        • Houston W.E.
        • Kremer R.J.
        • Crabbs C.L.
        • et al.
        Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: Enhanced primary immune response and altered pattern of antibody class elicited.
        J Infect Dis. 1977; 135: 600-610
        • Hubalek Z.
        • Halouzka J.
        West Nile fever: A reemerging mosquito-borne viral disease in Europe.
        Emerg Infect Dis. 1999; 5: 643-650
        • Huggins J.W.
        Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug.
        Rev Infect Dis. 1989; 11: S750-761
        • Jaax N.
        • Jahrling P.
        • Geisbert T.
        • et al.
        Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.
        Lancet. 1995; 346: 1669-1671
        • Jaax N.K.
        • Davis K.J.
        • Geisbert T.J.
        • et al.
        Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure.
        Arch Pathol Lab Med. 1996; 120: 140-155
        • Jackson A.C.
        • Sen Gupta S.K.
        • Smith J.F.
        Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters.
        Vet Pathol. 1991; 28: 410-418
        • Jahrling P.B.
        • Peters C.J.
        • Stephen E.L.
        Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys.
        J Infect Dis. 1984; 149: 420-427
        • Johnson E.
        • Jaax N.
        • White J.
        • et al.
        Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.
        Int J Exp Pathol. 1995; 76: 227-236
        • Johnston R.
        • Peters C.
        Alphaviruses.
        in: Fields B. Knipe D. Howley P. Fields Virology. ed 3. Lippincott-Raven, Philadelphia1996: 844-886
        • Kalter S.S.
        • Rodriguez A.R.
        • Cummins L.B.
        • et al.
        Experimental smallpox in chimpanzees.
        Bull World Health Organ. 1979; 57: 637-641
        • Knight V.
        • Gilbert B.E.
        Chemotherapy of respiratory viruses.
        Adv Intern Med. 1986; 31: 95-118
        • Kubes V.
        • Rios F.
        The causative agent of infectious equine encephalomyelitis in Venezuela.
        Science. 1939; 90: 20-21
        • Kuhn R.J.
        • Niesters H.G.
        • Hong Z.
        • et al.
        Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus.
        Virology. 1991; 182: 430-441
        • Lanciotti R.S.
        • Roehrig J.T.
        • Deubel V.
        • et al.
        Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern U.S.
        Science. 1999; 286: 2333-2337
        • Liljestrom P.
        • Lusa S.
        • Huylebroeck D.
        • et al.
        In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: The small 6,000-molecular-weight membrane protein modulates virus release.
        J Virol. 1991; 65: 4107-4113
        • Lukaszewski R.A.
        • Brooks T.J.
        Pegylated alpha interferon is an effective treatment for virulent Venezuelan equine encephalitis virus and has profound effects on the host immune response to infection.
        J Virol. 2000; 74: 5006-5015
        • Lvov D.K.
        • Butenko A.M.
        • Gromashevsky V.L.
        • et al.
        Isolation of two strains of West Nile virus during an outbreak in southern Russia, 1999.
        Emerg Infect Dis. 2000; 6: 373-376
        • Mahr J.A.
        • Gooding L.R.
        Immune evasion by adenoviruses.
        Immunol Rev. 1999; 168: 121-130
        • Martinez M.J.
        • Bray M.P.
        • Huggins J.W.
        A mouse model of aerosol-transmitted orthopox-viral disease: Morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB/c mouse system.
        Arch Pathol Lab Med. 2000; 124: 362-377
        • Monath T.P.
        • Heinz F.X.
        Flaviviruses.
        in: Fields N.D. Knipe D.M. Howley P. Fields Virology. ed 3. Lippincott-Raven, Philadelphia1996: 961-997
        • Moshkov S.P.
        • Grabareva L.P.
        • Moshkov A.E.
        • et al.
        The immunity generated in white rats vaccinated with strains of the Venezuelan equine encephalomyelitis virus.
        Vopr Virusol. 1991; 36: 417-419
        • Mupapa K.
        • Massamba M.
        • Kibadi K.
        • et al.
        Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients: International Scientific and Technical Committee.
        J Infect Dis. 1999; 179: S18-23
        • Murphy B.R.
        • Chanock R.M.
        Immunization against virus disease.
        in: Fields B.N. Knipe D.M. Howley P.M. Fields Virology, vol 1. Lippincott-Raven Publishers, Philadelphia1996: 467-497
        • Neufeld I.T.A.
        • Powanda M.C.
        • De Paoli A.
        • et al.
        Host metabolic alterations during Venezuelan equine encephalitis in the rat.
        J Lab Clin Med. 1978; 91: 255-263
      67. Outbreak of Ebola viral hemorrhagic fever—Zaire, 1995.
        MMWR Morb Mortal Wkly Rep. 1995; 44: 381-382
      68. Outbreak of West Nile-like viral encephalitis—New York, 1999.
        MMWR Morb Mortal Wkly Rep. 1999; 48: 845-849
      69. Outbreak of Rift Valley Fever—Saudi Arabia, August-October, 2000.
        MMWR Morb Mortal Wkly Rep. 2000; 49: 905-908
        • Peters C.
        • Zaki S.
        Overview of hemorrhagic fevers.
        in: Guerrant R. Walker D. Weller P. Tropical Infectious Diseases. Churchill Livingstone, Philadelphia1999: 1182-1190
        • Peters C.J.
        • Reynolds J.A.
        • Slone T.W.
        • et al.
        Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
        Antiviral Res. 1986; 6: 285-297
        • Phelps G.
        Vee in Texas: An on-the-scene report (July 28, 1971).
        Vet Med Small Anim Clin. 1971; 66: 911-913
        • Pittman P.R.
        • Makuch R.S.
        • Mangiafico J.A.
        • et al.
        Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine.
        Vaccine. 1996; 14: 337-343
        • Powers A.M.
        • Brault A.C.
        • Kinney R.M.
        • et al.
        The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants.
        J Virol. 2000; 74: 4258-4263
        • Pratt W.D.
        • Gibbs P.
        • Pitt M.L.
        • et al.
        Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
        Vaccine. 1998; 16: 1056-1064
        • Pushko P.
        • Bray M.
        • Ludwig G.V.
        • et al.
        Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
        Vaccine. 2000; 19: 142-153
        • Pushko P.
        • Parker M.
        • Ludwig G.V.
        • et al.
        Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
        Virology. 1997; 239: 389M01
        • Reynolds J.A.
        • Kastello M.D.
        • Harrington D.G.
        • et al.
        Glucan-induced enhancement of host resistance to selected infectious diseases.
        Infect Immun. 1980; 30: 51-57
        • Rice C.M.
        • Levis R.
        • Strauss J.H.
        • et al.
        Production of infectious RNA transcripts from Sindbis virus cDNA clones: Mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants.
        J Virol. 1987; 61: 3809-3819
      80. Richmond J.Y. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 492 BURGESS et al. ed 4. US Department of Health and Human Services, Centers for Disease Control, Office of Health and Safety, Washington1999
      81. Rift Valley fever—Egypt, 1993.
        MMWR Morb Mortal Wkly Rep. 1994; 43 (699-700): 693
      82. Rift Valley Fever—East Africa, 1997-1998.
        MMWR Morb Mortal Wkly Rep. 1998; 47: 261-264
        • Sabin A.B.
        • Baker A.B.
        • Haymaker W.
        • et al.
        Epidemiology of arthropod-borne encephalitis.
        Neurology. 1958; 8: 878-888
        • Sanchez A.
        • Ksiazek T.G.
        • Rollin P.E.
        • et al.
        Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates.
        J Infect Dis. 1999; 179: S164-169
        • Schoneboom B.A.
        • Catlin K.M.K.
        • Marty A.M.
        • et al.
        Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice.
        J Neuroimmunol. 2000; 109: 132-146
        • Schoneboom B.A.
        • Fultz M.J.
        • Miller T.H.
        • et al.
        Astrocytes as targets for Venezuelan equine encephalitis virus infection.
        J Neurovirol. 1999; 5: 342-354
        • Schoneboom B.A.
        • Lee J.S.
        • Grieder F.B.
        Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice.
        J Interferon Cytokine Res. 2000; 20: 205-215
        • Sergeev A.N.
        • Ryzhikov A.B.
        • Bulychev L.E.
        • et al.
        Study of the treatment-prophylactic effect of immunomodulators in experimental infections, caused by Marburg, Ebola, and Venezuelan equine encephalitis viruses.
        Vopr Virusol. 1997; 42: 226-229
      89. Smallpox in Birmingham.
        BMJ. 1978; 2: 837
        • Smith J.F.
        • Davis K.
        • Hart M.K.
        • et al.
        Viral encephalitides.
        in: Zajtchuk R.A.B. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, Part I. Office of the Surgeon General, Department of the Army, Washington1997: 561-589
        • Steele K.E.
        • Davis K.J.
        • Stephan K.
        • et al.
        Comparative neuro virulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice.
        Vet Pathol. 1998; 35: 386-397
        • Steele K.E.
        • Linn M.J.
        • Schoepp R.J.
        • et al.
        Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York.
        Vet Pathol. 2000; 37: 208-224
        • Sudia W.D.
        • Newhouse V.F.
        • Beadle I.D.
        • et al.
        Epidemic Venezuelan equine encephalitis in North America in 1971: Vector studies.
        Am J Epidemiol. 1975; 101: 17-35
        • Tsai T.
        Arboviral encephalitides.
        in: Strickland G. Hunter’s Tropical Medicine and Emerging Infectious Diseases. WB Saunders, Philadelphia2000: 267-268
        • van Eeden P.J.
        • van Eeden S.F.
        • Joubert J.R.
        • et al.
        A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II. Management of patients.
        S Afr Med J. 1985; 68: 718-721
        • van Ginkel F.W.
        • Nguyen H.H.
        • McGhee J.R.
        Vaccines for mucosal immunity to combat emerging infectious diseases.
        Emerg Infect Dis. 2000; 6: 123-132
        • Velzing J.
        • Groen J.
        • Drouet M.T.
        • et al.
        Induction of protective immunity against Dengue virus type 2: Comparison of candidate live attenuated and recombinant vaccines.
        Vaccine. 1999; 17: 1312-1320
        • Villinger F.
        • Rollin P.E.
        • Brar S.S.
        • et al.
        Markedly elevated levels of interferon-gamma, IFN-alpha, IL-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.
        J Infect Dis. 1999; 179: S188-191
        • Vogel P.
        • Abplanalp D.
        • Kell W.
        • et al.
        Venezuelan equine encephalitis in BALB/c mice: Kinetic analysis of central nervous system infection following aerosol or subcutaneous inoculation.
        Arch Pathol Lab Med. 1996; 120: 164-172
        • Vogel P.
        • Fritz D.L.
        • Kuehl K.
        • et al.
        The agents of biological warfare.
        JAMA. 1997; 278: 438-439
        • Watts D.M.
        • Callahan J.
        • Rossi C.
        • et al.
        Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region.
        Am J Trop Med Hyg. 1998; 58: 35-40
        • Weaver S.C.
        • Salas R.
        • Rico-Hesse R.
        • et al.
        Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group.
        Lancet. 1996; 348: 436-440
        • Wehrle P.F.
        • Posch J.
        • Richter K.H.
        • et al.
        An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe.
        Bull World Health Organ. 1970; 43: 669-679
        • Weissenbacher M.C.
        • Avila M.M.
        • Calello M.A.
        • et al.
        Effect of ribavirin and immune serum on Junin virus-infected primates.
        Med Microbiol Immunol. 1986; 175: 183-186
        • World Health Organization
        The Global Eradication of Smallpox. Final Report of the Global Commission for the Certification of Smallpox Eradication. (History of International Public Health, No.4). World Health Organization, Geneva1980
        • Zaki S.R.
        • Shieh W.-J.
        • Greer P.W.
        • et al.
        A novel immunohistochemical assay for the detection of Ebola virus in skin: Implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever.
        J Infect Dis. 1999; 179: S36-S47

      Article info

      Footnotes

      This work is supported by the TriService Nursing Research Program Grant No. MDA-905-98-Z-0020 and the Army Medical Research Grant No. DAMD-17-99-1-9484. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, the Department of the Army, the Department of Defense, or the United States government.

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30019-2

      Copyright

      © 2001 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX